AgraFlora’s Delta Greenhouse Commences Cultivation
VANCOUVER, British Columbia, June 15, 2020 (GLOBE NEWSWIRE) — AgraFlora Organics International Inc. (“AgraFlora” or the “Company”) (CSE: AGRA) (Frankfurt: PU31) (OTCPK: […]
Zealand Pharma strengthens executive team with new U.S. leadership
Company announcement – No. 33 / 2020Zealand Pharma strengthens executive team with new U.S. leadershipCopenhagen, June 15, 2020 – Zealand […]
Extraction Oil & Gas, Inc. Files for Chapter 11 Protection
DENVER, June 14, 2020 (GLOBE NEWSWIRE) — Extraction Oil & Gas, Inc. (NASDAQ: XOG) (together with its subsidiaries, “Extraction” or […]
African Gold Group Announces Board and Senior Management Restructuring and Name Change as It Moves Into the Construction Phase
Danny Callow appointed as President and Chief Executive Officer;Scott Eldridge appointed as Non-Executive Chairman of the Board;Jan-Erik Back appointed as […]
Pilgrim’s CEO on Paid Leave of Absence
GREELEY, Colo., June 14, 2020 (GLOBE NEWSWIRE) — Pilgrim’s Pride Corporation (NASDAQ: PPC) today announced that president and CEO Jayson […]
Esperion Announces Pooled Analysis from Phase 3 LDL-C Lowering Clinical Development Program of NEXLETOL™ (Bempedoic Acid) Tablets Presented at the American Diabetes Association 80th Scientific Sessions
ANN ARBOR, Mich., June 14, 2020 (GLOBE NEWSWIRE) — Esperion (NASDAQ: ESPR) today announced that pooled analysis from four Phase […]
Investigator-Initiated Study Shows Switching to Afrezza® Improves Glucose Control with No Additional Hypoglycemia in T2DM
WESTLAKE VILLAGE, Calif., June 13, 2020 (GLOBE NEWSWIRE) — MannKind Corporation (Nasdaq: MNKD) announced that data from a new clinical […]
Lexicon Pharmaceuticals Presents Clinical Data at 80th American Diabetes Association Scientific Sessions
THE WOODLANDS, Texas, June 13, 2020 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today presented six posters for ZynquistaTM […]
Zealand Pharma presents elaborated results on the use of regular human insulin delivered by V-Go® in older adults with type 2 diabetes, at the 80th Scientific Sessions of the American Diabetes Association
Press release – No. 08 / 2020Zealand Pharma presents elaborated results on the use of regular human insulin delivered by […]
vTv Therapeutics Presents Two Late-Breaking Poster Sessions on Simplici-T1 Study at the American Diabetes Association’s Virtual Sessions Supporting the Potential of TTP399 as First-in-Class Oral Adjunctive Therapy for Type 1 Diabetes Patients
– Treatment with TTP399 resulted in significant improvements in HbA1c with reduction in insulin, without increasing risk of hypoglycemia or […]
